Hepatitis B Virus Genotype and Mutants: Risk Factors for Hepatocellular Carcinoma

Josep M. Llovet; Anna S. Lok

doi:10.1093/jnci/djn261

Related publications

Article2003

Hepatitis B virus and hepatocellular carcinoma

Jordi Bruix, Josep M. Llovet

Letter2011

Smoking, Hepatitis B Virus Infection, and Development of Hepatocellular Carcinoma

Morris Sherman, Josep M. Llovet

JNCI Journal of the National Cancer Institute

Article2020

Impact of baseline hepatitis B viremia and management on outcomes in advanced hepatocellular carcinoma and elevated alpha-fetoprotein: outcomes from REACH-2

Peter R. Galle, Masatoshi Kudo, Josep M. Llovet, Richard S. Finn, Mark Karwal, Denis Pezet, Tae‐You Kim, Tsai‐Sheng Yang, Vittorina Zagonel, Jiří Tomášek, Jean-Marc Phélip, Yann Touchefeu, Su‐Jin Koh, Guido Stirnimann, Chunxiao Wang, Kenyon D. Ogburn, Paolo Abada, Ryan C. Widau, Andrew X. Zhu

Journal of Hepatology

Article2017

hepatitis b virus related membranous nephropathy superimposed on crescentic nephritis induced by anca associated vasculitis

Song Wang, Haijing Liu, Wenxue Tang

Article2021

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet, Florian Castet, Mathias Heikenwälder, Mala K. Maini, Vincenzo Mazzaferro, David J. Pinato, Eli Pikarsky, Andrew X. Zhu, Richard S. Finn

Nature Reviews Clinical Oncology